Why Are Men More Likely to Be Color Blind?

Unpack the science behind color vision deficiency. Learn how chromosome structure determines the massive statistical difference in male vs. female prevalence.

Red-green color blindness runs on the X chromosome, and because men have only one X (paired with a Y), a single defective gene copy is enough to cause the condition. Women, with two X chromosomes, need defective copies on both to be affected. This basic asymmetry in sex chromosomes is the reason roughly eight percent of men of European descent are red-green color blind, compared to well under one percent of women. But the story is richer than textbook inheritance alone, touching on everything from why color blindness may have been useful to our ancestors to why some carrier women might actually see more colors than the rest of us.

The X Chromosome Bottleneck

Your ability to see red and green depends on two genes that sit right next to each other on the X chromosome. One codes for the photopigment in your long-wavelength (“red”) cones and the other for the photopigment in your medium-wavelength (“green”) cones. When either gene is mutated, deleted, or reshuffled, the corresponding cone type does not work properly, and red-green color discrimination suffers. Because these genes are X-linked and the trait is recessive, a woman who inherits a faulty copy on one X chromosome almost always has a normal copy on the other X to compensate. She becomes a carrier but typically sees colors normally. A man who inherits that same faulty copy on his single X has no backup. The defective gene is the only instruction set his cones get.

The two opsin genes are strikingly similar in their DNA sequences and arranged in a head-to-tail line on the chromosome. That physical layout invites errors during cell division: sections of the red and green genes can swap, fuse into hybrid genes, or get deleted entirely through a process of unequal recombination. This is not a rare accident. The mutation rate for these genes is high compared to most parts of the genome, which helps explain why color vision deficiency is so common in the first place.

How Common Is It, and Does It Vary by Population?

Among men of European ancestry, about eight percent are red-green color deficient, while the rate in women is around 0.4 percent. That roughly twenty-to-one male-to-female ratio is what you’d predict from X-linked recessive inheritance. The rates are not uniform worldwide, though. Men of Chinese and Japanese ethnicity show prevalence between about four and six-and-a-half percent, and rates in African populations have historically been lower, though recent surveys suggest they are rising, possibly as populations mix and migrate.

A large meta-analysis covering data from 1932 through 2022, focused on children and adolescents, found a global prevalence of about 4.4 percent in boys and 0.6 percent in girls. The children’s data confirmed the same ethnic patterns, with European-descent populations at the top and close behind them those of African descent. The slight differences in exact percentages between adult and pediatric surveys likely reflect differences in how populations were sampled rather than any real change with age: congenital color vision deficiency is present from birth and does not worsen or improve over time.

What Happens in Carrier Women

About fifteen percent of women of European descent carry one altered red or green opsin gene. Most of these carriers pass standard color vision tests and have no idea they carry the trait. But something unusual is happening in their retinas. Because of X-inactivation, where each cell randomly shuts down one of its two X chromosomes, a carrier woman’s retina ends up with a patchwork: some cone cells express the normal pigment from one X, and neighboring cones express the altered pigment from the other X. The result is that she can end up with four distinct cone types instead of the usual three.

Whether this actually grants these women richer color perception, a kind of “tetrachromacy,” has been debated for decades. The logic is straightforward: more cone types means more possible comparisons between signals, which in principle means finer color discrimination. This phenomenon has a parallel in New World monkeys, where females heterozygous for different opsin gene variants gain trichromatic vision in a species that is otherwise dichromatic. In at least some carrier women, the ratio of different cone types in the retina is skewed by uneven X-inactivation, and the degree of that skew may determine whether the extra cone type offers a measurable perceptual advantage or just sits there without adding much. The evidence so far is that most carrier women have normal or near-normal color vision, but a small subset may genuinely see color distinctions that three-cone people cannot.

Types of Color Blindness That Do Not Follow the X-Linked Pattern

Not all color vision deficiencies favor men. Tritanopia, a rare deficiency affecting blue-yellow discrimination, is caused by mutations in the gene for the short-wavelength (“blue”) cone pigment, which sits on chromosome 7, not the X chromosome. It is inherited as a dominant trait and affects men and women at the same rate. Achromatopsia, or total color blindness, is rarer still and involves the complete failure of all cone types. It is autosomal recessive, so it also hits both sexes equally. When people talk about “color blindness” in everyday conversation, though, they almost always mean red-green deficiency, which accounts for the vast majority of cases and is the type overwhelmingly concentrated in men.

Color vision can also be lost during a person’s lifetime rather than inherited. Certain medications are known to damage color perception. Hydroxychloroquine, used for autoimmune conditions, tends to cause blue-yellow defects early and red-green defects as retinal toxicity advances. Ethambutol, a tuberculosis drug, is associated with blue-yellow loss through optic nerve damage. Even sildenafil can temporarily tint vision blue by interfering with the signaling pathway inside cones. These acquired deficiencies are not sex-linked at all. Anyone taking the drug is at risk, regardless of their chromosomes. The distinction matters because someone who develops color vision changes in adulthood should not assume it is the same harmless congenital condition that runs in families; it could signal medication toxicity or an underlying neurological problem that needs attention.

Why Hasn’t Evolution Eliminated Color Blindness?

A trait that affects nearly one in twelve men and has been around for thousands of generations would normally be expected to fade if it were purely harmful. One explanation is that the high mutation rate at the opsin gene cluster keeps producing new cases faster than natural selection can remove them. But there are hints that color blindness may not be purely disadvantageous. In a study designed to test whether dichromats could break certain kinds of camouflage, researchers found that people with red-green color blindness outperformed trichromats when a target was hidden against a background of randomly colored red and green elements. The color variation distracted normal-vision participants but had no effect on the dichromats, who effectively saw through the camouflage.

Work on primate color vision supports a similar idea. In species where some individuals are trichromatic and others dichromatic, the two groups appear to have complementary strengths. Trichromats are better at spotting ripe fruit against green foliage, while dichromats are better at detecting certain predators or camouflaged insects. In a social group where both types are represented, everyone benefits. This sort of “balanced polymorphism,” where keeping some variation in the population is better than everyone being identical, could explain why the genes for red-green deficiency have persisted rather than being weeded out.

The evolutionary history of opsin genes themselves tells a related story. In Old World primates, including humans, the red and green opsin genes arose from a duplication event on the X chromosome. Most New World monkeys still have only a single opsin gene on their X, with several variant forms floating around in the population. All males in these species are dichromats. Only females who happen to inherit two different opsin variants, one on each X, gain trichromacy. This system has apparently worked well enough to persist for millions of years in dozens of species, which suggests that a population does not need every individual to be trichromatic to thrive.

Testing and When It Matters

Most people discover they are color blind through the Ishihara plate test, those circles filled with colored dots that hide a number. It is a well-validated screening tool: a review of data from hundreds of men with confirmed anomalous trichromacy found that the Ishihara plates caught about 98 percent of cases when a participant made three or more errors. It is much better at catching color vision deficiency than the alternative Hardy-Rand-Rittler plates, which missed too many mild cases to be reliable as a standalone screen. For precise classification, the gold standard is the Nagel anomaloscope, a device that asks you to match a yellow light by mixing red and green. Where you set the dial reveals exactly how your cone sensitivities differ from average.

Newer technology is catching up. An iPhone-based anomaloscope recently demonstrated 100 percent diagnostic accuracy in validation testing confirmed against genetic analysis. If smartphone-based testing becomes widely available, it could make precise diagnosis accessible in settings where specialized equipment is not practical, like school screenings or remote clinics.

For children, early detection is more than academic. A study of schoolchildren in South Africa found that kids with congenital color vision deficiency had significant difficulties with color-dependent tasks both in the classroom and in daily life compared to peers with normal vision. When teachers do not know a child is color deficient, they may misread struggles with color-coded materials as inattention or a learning difficulty. A simple screening can reframe the problem entirely.

Jobs, Regulations, and Everyday Frustrations

Color vision standards in transportation have been in place for over a century. Pilots, train drivers, and maritime navigators all face screening requirements designed to ensure they can distinguish safety-critical colored signals. These standards are regularly challenged by people they exclude, and anti-discrimination laws have prompted several countries to revisit how strictly they should be applied. The UK Civil Aviation Authority, for example, now uses the Color Assessment and Diagnosis (CAD) test instead of blanket pass-fail plate tests. The CAD approach allows applicants who can demonstrate they perform safety-critical color tasks as accurately as normal trichromats to qualify for pilot training, even if their color vision is technically deficient by older standards.

Outside regulated industries, color blindness creates a steady hum of low-grade frustration rather than outright danger. Cooking meat to the right color, picking matching clothes, reading color-coded charts at work, distinguishing status lights on electronics, and interpreting traffic lights by position rather than color are all minor adaptations that most color-blind men internalize so completely they rarely think about them. Digital interfaces have improved significantly: many operating systems and apps now offer color-blind-friendly modes, and good design practice increasingly calls for redundant cues like patterns or labels alongside color. The shift is slow, though, and plenty of graphs, maps, and dashboards still rely on red-green distinctions alone.

Gene Therapy and the Future

The most dramatic research development in this space came from experiments in squirrel monkeys, which are naturally dichromatic. Researchers used a viral vector to deliver a human long-wavelength opsin gene into the retinas of adult male monkeys that had never experienced red-green color vision. About twenty weeks after treatment, the animals began passing color discrimination tests they had previously failed, behaving in ways consistent with newly acquired trichromacy. The result was startling partly because it challenged the assumption that the brain’s color-processing circuits need to develop during a critical window in early life. The monkeys’ brains appeared capable of interpreting signals from a cone type they had never had before, even in adulthood.

Human trials have not yet happened, and there are real hurdles. Getting the viral vector into enough cone cells across the retina, ensuring long-term stable expression of the new pigment, and confirming safety over years rather than months are all unresolved. Red-green color deficiency also does not cause blindness or progressive vision loss, so the risk-benefit calculation for an invasive procedure is different from gene therapies for blinding diseases like Leber congenital amaurosis, which have already reached clinical use. Still, the primate proof of concept established that the adult visual system is plastic enough to accommodate a genuinely new dimension of color. If delivery methods improve and safety data accumulate, corrective gene therapy for color blindness in humans is plausible within the coming decades.

John Dalton’s Eyes

The man whose name became synonymous with color blindness in many languages, John Dalton, described his own condition in 1794 and believed it was caused by a bluish tint in the fluid inside his eye. He requested that his eyes be examined after death to test this idea. When they finally were, the vitreous humor turned out to be perfectly clear. The mystery lingered for two centuries until 1995, when researchers extracted DNA from Dalton’s preserved eye tissue and determined that he was a deuteranope, missing the medium-wavelength cone pigment entirely. The analysis confirmed what genetics would have predicted all along: his condition was X-linked, congenital, and had nothing to do with the fluid in his eyes. Dalton was wrong about the mechanism but right that something real was different about his perception, and the fact that it took two hundred years to pin down the molecular cause speaks to how slowly the tools for understanding color vision caught up with the experience of living without it.